Association between treatment decisions and survival outcomes in lung cancer patients under a multidisciplinary team model: the impact of MDT-recommended treatment plans on treatment completion rates, survival time, and treatment conversion - Scorecard - MDSpire

Association between treatment decisions and survival outcomes in lung cancer patients under a multidisciplinary team model: the impact of MDT-recommended treatment plans on treatment completion rates, survival time, and treatment conversion

  • By

  • Qian Yi

  • Hailong Wei

  • May 4, 2026

  • 0 min

Share

Clinical Scorecard: Impact of Multidisciplinary Team Recommendations on Treatment Choices and Survival in Lung Cancer Patients

At a Glance

CategoryDetail
ConditionLung Cancer
Key MechanismsMultidisciplinary Team (MDT) discussions enhance treatment adherence and survival outcomes.
Target PopulationPatients with primary lung cancer receiving first anti-cancer treatment.
Care SettingSingle-center oncology practice.

Key Highlights

  • MDT group had a higher treatment completion rate (86.09% vs. 68.57%).
  • Lower treatment conversion rate in MDT group (19.13% vs. 39.05%).
  • MDT participation linked to longer median overall survival (45.21 vs. 28.64 months).
  • MDT group experienced longer progression-free survival (19.80 vs. 13.53 months).
  • MDT participation is an independent factor for improved outcomes.

Guideline-Based Recommendations

Diagnosis

  • Pathologically confirm lung cancer (NSCLC or SCLC).
  • Utilize comprehensive diagnostic assessments.

Management

  • Implement MDT discussions for treatment planning.
  • Tailor treatment based on tumor biology and patient characteristics.

Monitoring & Follow-up

  • Regular follow-up to assess treatment adherence and outcomes.
  • Monitor for unplanned treatment modifications.

Risks

  • Potential for conflicting recommendations without MDT.
  • Risk of delayed treatment initiation in fragmented care.

Patient & Prescribing Data

Adults aged ≥18 years with newly diagnosed lung cancer.

MDT recommendations improve adherence and survival metrics.

Clinical Best Practices

  • Engage in MDT discussions for all lung cancer cases.
  • Ensure comprehensive data collection for treatment planning.
  • Facilitate patient-centered decision-making through MDT consensus.

References

Original Source(s)

Association between treatment decisions and survival outcomes in lung cancer patients under a multidisciplinary team model: the impact of MDT-recommended treatment plans on treatment completion rates, survival time, and treatment conversion

  • by Qian Yi, Hailong Wei

  • May 4, 2026

Related Content

Artificial intelligence for optimization of immunotherapy: current applications and transformative potential

Recurrent pleuropulmonary blastoma type III initially misclassified as embryonal rhabdomyosarcoma on limited biopsy: a case report with pathogenic DICER1 variant

Is full adherence mandatory? Real-world outcomes of completing perioperative chemoimmunotherapy in resectable non-small cell lung cancer